[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 220 Committee Discharged Senate (CDS)]

103d CONGRESS
  1st Session
H. J. RES. 220


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

               August 6 (legislative day, June 30), 1993

  Received; read twice and referred to the Committee on the Judiciary

           September 10 (legislative day, September 7), 1993

                          Committee discharged

_______________________________________________________________________

                            JOINT RESOLUTION


 
 To designate the month of August as ``National Scleroderma Awareness 
                    Month'', and for other purposes.

Whereas scleroderma is a disease caused by the excess production of collagen, 
        the main fibrous component of connective tissue, causing hardening of 
        the skin or internal organs, or both, such as the esophagus, lungs, 
        kidney, and heart;
Whereas approximately 300,000 people in the United States suffer from 
        scleroderma, with women of childbearing age outnumbering men 4 to 1;
Whereas scleroderma, a painful, crippling, and disfiguring disease, is most 
        often progressive and can result in premature death;
Whereas the symptoms of scleroderma are variable which can complicate and 
        confuse diagnosis;
Whereas the cause and cure of scleroderma are unknown; and
Whereas scleroderma is an orphan disease that requires intensive research to 
        improve treatment as well as find the cause and cure: Now, therefore, be 
        it
    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That the months of August 1993 
and August 1994 are designated as ``National Scleroderma Awareness 
Month''. The President is authorized and requested to issue a 
proclamation calling on the people of the United States to observe each 
such month with appropriate activities that will enhance awareness of 
the disease and the need for a cure.

            Passed the House of Representatives August 5, 1993.

            Attest:

                                           DONNALD K. ANDERSON,

                                                                 Clerk.